Full Year 2022 MDxHealth SA Earnings Call Transcript
Greetings. Welcome to the MDxHealth fourth quarter and full-year 2022 earnings call. (Operator Instructions) Please note this conference is being recorded.
Before we begin, I would like to remind everyone that we will make forward-looking statements during today's call, whether in prepared remarks or during the Q&A session. These forward-looking statements are subject to inherent risks and uncertainties. These risks and uncertainties are detailed in the risk factors section of our filings with the Securities and Exchange Commission, specifically in the company's annual report on Form 20-F.
I will now turn the conference over to your host, Michael McGarrity, Chief Executive Officer. You may begin.
Thanks, Shomali. Thank you all for joining us for our 2022 full-year release of results for MDxHealth. With me today is Ron Kalfus, Chief Financial Officer.
As you are likely aware, prostate cancer is the most common form of cancer in men. When I joined MDxHealth in 2019, my vision was to continue
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |